U.S. Biotech Stock News

Over the last 7 days, the U.S. market has remained flat, though it is up 20% over the past year with earnings forecasted to grow by 18% annually. Investing in penny stocks—often associated with smaller or newer companies—can still open doors to growth opportunities when these stocks are backed by strong financial health. In this context, we will explore several penny stocks that stand out for their financial strength and potential for long-term success.

Independent Bank Corp. recently announced it would release its second-quarter 2026 earnings on July 16, with analysts expecting earnings of US$1.77–US$1.78 per share and revenue of about US$257.73–US$258.95 million. These expectations, alongside a fresh US$0.64 per-share dividend declaration and ongoing analyst estimate revisions, are sharpening investor focus on the bank’s near-term performance. We’ll now examine how the upcoming earnings release and stronger earnings expectations may...

New U.S. tariffs of 25% on thousands of Brazilian imports are set to reshape how agricultural and industrial goods move around the world, with roughly $15b in trade directly in the crosshairs. For investors, that kind of shock can quickly split stocks into potential winners and potential losers as input costs, export routes, and customer demand all adjust. This article walks through three stocks exposed to the tariff story, showing how one could find support from shifting trade flows while...

Agenus (AGEN) is back in focus after fresh Phase 1b data on its botensilimab plus balstilimab regimen in refractory microsatellite stable metastatic colorectal cancer, as well as an oversubscribed private placement tied to its planned ROBBIN Phase 3 trial. See our latest analysis for Agenus. Agenus has been highly volatile, with the share price return up 45.1% over the past week and 57.3% year to date, but the 1 year total shareholder return is still down 18.3% and the 5 year total...

Redwire (NYSE:RDW) secured US$21.5 million in follow-on awards to supply uncrewed aircraft systems to the U.S. Marine Corps. The contracts cover additional Advanced Stalker Block 30 systems that align with the Marine Corps' ISR modernization plans. The awards extend an existing relationship, reflecting continued use of Redwire's platform in U.S. defense programs. For investors tracking Redwire, this latest contract underscores the company’s role in supplying uncrewed aircraft systems to...

After a very strong run over the past five years, Modine Manufacturing now screens as only fairly valued on a Discounted Cash Flow (DCF) intrinsic value estimate, while traditional market multiples suggest that the stock is on the expensive side. Modine Manufacturing has delivered a very large 5 year return of about 13x, which means recent buyers are stepping into a stock that has already rewarded long term holders significantly. The planned combination of Modine's Performance Technologies...

Carnival Corporation is highlighting its Alaska business as a key long-term growth driver, with a focus on integrated cruise and land experiences. The company is investing in higher-value Alaska packages, including expansion of its Denali lodge facilities. This shift positions Alaska as a central part of Carnival's broader business strategy for future expansion. Carnival (NYSE:CCL) is putting fresh emphasis on Alaska at a time when its stock trades around $26.5, with a mixed return profile...

ASML Holding (NasdaqGS:ASML) reports strong Q2 2026 results and raises its quarterly and full-year 2026 sales and margin guidance. Intel Foundry uses ASML's High NA EUV tools for production chips, marking the first high-volume output on this new lithography standard. Management cites robust AI-related demand and outlines plans for significant capacity expansion to support customers. ASML Holding sits at the center of advanced chip production, supplying lithography systems that are essential...

Vertex Pharmaceuticals (NasdaqGS:VRTX) agreed to acquire Crinetics Pharmaceuticals in a US$10b all cash transaction. The deal brings atumelnant, an advanced clinical stage drug candidate for congenital adrenal hyperplasia, into Vertex's pipeline. The acquisition marks a move by Vertex into adrenal disease therapeutics, expanding beyond its traditional focus areas. For investors following Vertex Pharmaceuticals, this deal signals a push beyond the company’s established franchises and into...

We wouldn't blame SharkNinja, Inc. ( NYSE:SN ) shareholders if they were a little worried about the fact that CJ Xuning...

We wouldn't blame Arcus Biosciences, Inc. ( NYSE:RCUS ) shareholders if they were a little worried about the fact that...

The proposed US$53b bid by Stripe and Advent International for PayPal has pushed digital payments and broader fintech back into the spotlight, with a 28% offer premium hinting at how highly some buyers value this space. For investors, that kind of interest can reshape expectations across the sector, from transaction platforms to tech driven financial services. This article looks at three fintech stocks from our Fintech Sector Stocks screener that are closely tied to this news and explains how...

CDW stock has fallen about 23% over the past three years, yet the current market price of US$139.38 still screens as cheap against its intrinsic value estimate from a Discounted Cash Flow (DCF) model and against earnings based multiples. The share price has declined 22.7% over three years, which means anyone looking at CDW today is assessing a stock that has already seen a meaningful reset. For long term holders, the key support for valuation is CDW's ability to convert revenue into steady...

Some Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) shareholders may be a little concerned to see that the Chief Legal...

Over the last 7 days, the United States market has remained flat, yet it has experienced a robust 20% increase over the past year with earnings forecasted to grow by 18% annually. In this environment, identifying small-cap stocks that are perceived as undervalued and show insider activity can offer intriguing opportunities for investors seeking potential growth.

In the last week, the United States market has stayed flat, yet it is up 20% over the past year with earnings forecasted to grow by 18% annually. In this environment, identifying stocks that are trading below their intrinsic value can be a strategic approach for investors seeking opportunities in potentially undervalued assets.

Over the last 7 days, the United States market has remained flat, yet over the past 12 months, it has experienced a notable rise of 20%, with earnings expected to grow by 18% per annum in the coming years. In this environment of growth potential, stocks that exhibit strong insider ownership can be particularly appealing as they suggest confidence from those closest to the company's operations and future prospects.

The United States market remained flat over the last week, yet it has seen a notable 20% rise over the past year, with earnings expected to grow by 18% annually in the coming years. While penny stocks might seem like an outdated term, they continue to represent a viable investment area for those seeking affordability and growth potential. By focusing on smaller or newer companies with strong financials, investors can uncover opportunities that may offer both stability and upside potential.

The United States market has remained flat over the last week but is up 20% over the past year, with earnings expected to grow by 18% per annum. In this context, identifying dividend stocks that offer stable payouts and potential for growth can be a prudent strategy for investors seeking reliable income amid fluctuating market conditions.

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

We wouldn't blame Planet Labs PBC ( NYSE:PL ) shareholders if they were a little worried about the fact that Robert...

SLB (NYSE:SLB) has formed an alliance with Liberty Energy to supply modular infrastructure and integrated power solutions for global data center projects. The partnership focuses on supporting power hungry AI data centers with hybrid power systems and digital energy management tools. The collaboration targets new and expanding data center developments worldwide that are linked to rising AI workloads. For SLB, which is widely known for its energy services and project delivery capabilities,...

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

We wouldn't blame Everpure, Inc. ( NYSE:P ) shareholders if they were a little worried about the fact that Charles...